phrykt

Boston Scientific Corp (BSX): who owns it and who trades it

As of Nov 16, 2026, BSX insiders reported 3 open-market sales worth $16.8M and 10 purchases worth $10M in the last 12 months, with 100% of the sale value made under pre-set 10b5-1 plans. The largest seller was Michael F Mahoney (CEO), with $15M. 8 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Boston Scientific

From the latest filings

Overall: about as much buying as selling. Famous investors and Congress mostly sold. Insiders mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns BSX

1,473 funds and institutions reported BSX shares worth $60.1B at the end of Q2 2026, about 97% of the company. The largest holder is BlackRock, Inc. with 8.7%.

Funds and institutions (13F) 97%Everyone else 3%

10 largest owners, by share of the company

BlackRock, Inc.8.7%
Vanguard Capital Management LLC6.5%
California State Teachers Retirement System6.5%
State Street Corp4.7%
Primecap Management Co3.4%
FMR LLC (Fidelity)3.1%
Geode Capital Management, LLC2.2%
Vanguard Portfolio Management LLC2.0%
D. E. Shaw & Co., Inc.1.7%
Massachusetts Financial Services Co1.7%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.129.68M8.72%$5.5B-2%
Vanguard Capital Management LLC97.09M6.53%$4.1B+1%
California State Teachers Retirement System96.91M6.52%$2.3B+4114%
State Street Corp70.11M4.72%$3B+3%
Primecap Management Co50.52M3.40%$2.2B+55%
FMR LLC (Fidelity)45.70M3.07%$2B-38%
Geode Capital Management, LLC33.44M2.25%$1.4B+0%
Vanguard Portfolio Management LLC29.79M2.00%$1.3BNo change
D. E. Shaw & Co., Inc.25.46M1.71%$1.1B+5%
Massachusetts Financial Services Co24.86M1.67%$1.5B+126%
JPMorgan Chase & Co23.91M1.61%$1B–
Arrowstreet Capital, Limited Partnership23.29M1.57%$994M+68%
Norges Bank21.17M1.42%$904M–
Two Sigma Investments, LP19.36M1.30%$826M+106%
Morgan Stanley18.95M1.27%$809M-15%
Jupiter Topco LLC18.82M1.27%$803M–
Bollard Group LLC18.42M1.24%$786M-1%
Goldman Sachs Group Inc16.95M1.14%$724M-10%
Capital World Investors16.81M1.13%$718M+10%
UBS Group AG16.35M1.10%$698M+10%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, BSX insiders reported $10M of open-market purchases and $16.8M of sales. 100% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$10M
10 trades, 5 people
Sales, 12 months
$16.8M
3 trades, 2 people
Sales under a 10b5-1 plan
100%
Share of sale value
Latest trade
Aug 25, 2026
Filed Aug 26, 2026

Purchases and sales by month

$15M$15MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 25, 2026Susan E MoranoDirectorPurchase2,040$49.22$100KForm 4
Aug 5, 2026David C HabigerDirectorPurchase2,100$47.59$99.9KForm 4
Aug 4, 2026David C HabigerDirectorPurchase140$48.59$6.8KForm 4
Aug 3, 2026David C HabigerDirectorPurchase1,042$48.07$50.1KForm 4
Aug 3, 2026Michael F MahoneyCEOPurchase186,240$48.33$9MForm 4
Jul 31, 2026Edward J LudwigDirectorPurchase5,000$45.48$227KForm 4
May 20, 2026Cheryl PegusDirectorPurchase1,770$56.49$100KForm 4
May 20, 2026Edward J LudwigDirectorPurchase3,580$56.68$203KForm 4
May 20, 2026David C HabigerDirectorPurchase2,250$55.92$126KForm 4
May 19, 2026David C HabigerDirectorPurchase2,200$56.95$125KForm 4
Feb 2, 2026Michael F MahoneyCEOSale plan159,701$93.49$14.9MForm 4
Feb 2, 2026Michael F MahoneyCEOSale plan1,200$94.06$113KForm 4
Dec 1, 2025Arthur C ButcherVice presidentSale plan17,313$101.55$1.8MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Michael F MahoneyChairman, President & CEO, Director$9M$15MAug 3, 2026
Arthur C ButcherEVP& Grp Pres, MedSurg & APAC–$1.8MDec 1, 2025
Edward J LudwigDirector$430K–Jul 31, 2026
David C HabigerDirector$408K–Aug 5, 2026
Susan E MoranoDirector$100K–Aug 25, 2026
Cheryl PegusDirector$100K–May 20, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BSX short interest

Low short interest. 2.4% of BSX shares are sold short: about 1 share in 41. Over the last 12 reports the number of shares short went up 12%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 35.11M BSX shares were sold short, 2.4% of the shares outstanding, down 13.7% from the report before. At the average daily volume of 21.26M shares, buying them all back would take about 1.6 trading days (days to cover).

Shares short, % of all shares

2.42%May 15Oct 304.22%

Days to cover

1.6May 15Oct 302.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202635.11M2.42%-14%21.26M1.6
Oct 15, 202640.71M2.81%-2%15.74M2.6
Sep 30, 202641.41M2.86%-11%21.98M1.9
Sep 15, 202646.50M3.21%-3%19.75M2.4
Aug 31, 202648.17M3.32%+74%21.04M2.3
Aug 14, 202627.62M1.91%+24%17.64M1.6
Jul 31, 202622.28M1.54%-21%21.97M1.0
Jul 15, 202628.28M1.90%+1%16.78M1.7
Jun 30, 202627.94M1.88%-6%23.40M1.2
Jun 15, 202629.75M2.00%-48%20.62M1.4
May 29, 202657.49M3.87%+83%25.51M2.2
May 15, 202631.42M2.11%+10%17.71M1.8

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded BSX

Since Nov 17, 2024, 8 members of Congress reported 14 purchases and 22 sales of BSX. The latest was a sale by Kevin Hern on Sep 9, 2026, reported Sep 25, 2026.

Purchases 14Sales 22

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Sep 9, 2026Kevin Hern (R-OK)Sale$50K–$100KJointSep 25, 2026Report
Sep 4, 2026Kevin Hern (R-OK)Partial sale$50K–$100KJointSep 25, 2026Report
Sep 3, 2026Kevin Hern (R-OK)Sale$1K–$15KChildSep 25, 2026Report
Aug 31, 2026Kevin Hern (R-OK)Sale$15K–$50KJointSep 25, 2026Report
Aug 18, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfSep 10, 2026Report
Jun 5, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfJul 2, 2026Report
Jun 5, 2026Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfJul 2, 2026Report
Jun 4, 2026John Boozman (R-AR)Partial sale$1K–$15KJointJul 13, 2026Report
May 29, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfJun 8, 2026Report
May 19, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfJun 8, 2026Report
May 11, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfJun 8, 2026Report
Mar 27, 2026Alan Armstrong (R-OK)Purchase$1K–$15KSelfJul 21, 2026Report
Feb 10, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfMar 9, 2026Report
Jan 30, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfFeb 13, 2026Report
Dec 24, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfJan 12, 2026Report
Dec 17, 2025John Boozman (R-AR)Partial sale$1K–$15KJointJan 13, 2026Report
Nov 18, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfDec 15, 2025Report
Oct 31, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseNov 21, 2025Report
Oct 28, 2025Kevin Hern (R-OK)Partial sale$15K–$50KJointNov 16, 2025Report
Oct 17, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfNov 18, 2025Report
Sep 23, 2025Val T. Hoyle (D-OR)Sale$1K–$15KSpouseOct 10, 2025Report
Aug 4, 2025Lisa C. McClain (R-MI)Partial sale$1K–$15KSpouseSep 12, 2025Report
Jul 31, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfAug 14, 2025Report
Jun 26, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfJul 10, 2025Report
Jun 11, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfJul 10, 2025Report
May 13, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfJun 6, 2025Report
May 12, 2025Jefferson Shreve (R-IN)Sale$15K–$50KSelfJun 22, 2025Report
Apr 28, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfMay 6, 2025Report
Apr 21, 2025Bruce Westerman (R-AR)Sale$1K–$15KSelfMay 12, 2025Report
Mar 17, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfApr 7, 2025Report
Mar 3, 2025Bruce Westerman (R-AR)Purchase$1K–$15KSelfApr 16, 2025Report
Feb 24, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfMar 6, 2025Report
Feb 13, 2025John Boozman (R-AR)Purchase$1K–$15KJointMar 6, 2025Report
Dec 11, 2024Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Boston Scientific company events

Boston Scientific filed 19 reports on Form 8-K in the last 12 months, 7 of them about an important change (leadership, cyberattack, job cuts). The latest was on Oct 28, 2026.

  1. Oct 28, 2026ResultsReleased financial results. Filing
  2. Oct 7, 2026LeadershipBoston Scientific Corporation announced that Joe Fitzgerald, who currently serves as Executive Vice President and Group President, Cardiovascular, has been promoted to Executive Vice President and Chief Operating Officer of the Company, effective as of January 1, 2027. Filing
  3. Sep 23, 2026LeadershipArthur C. Butcher informed Boston Scientific Corporation that he has decided to retire from his role as Executive Vice President and Group President, MedSurg and Asia Pacific effective as of January 1, 2027. Filing
  4. Sep 8, 2026CyberattackAs previously disclosed in a Current Report on Form 8-K filed on August 26, 2026 with the Securities and Exchange Commission, on August 25, 2026, Boston Scientific Corporation identified a cybersecurity incident that affected certain of its information technology systems and resulted in a global… Filing
  5. Aug 26, 2026AnnouncementBoston Scientific Corporation identified a cybersecurity incident affecting certain of its information technology systems that has resulted in a global disruption to the Company’s operations. Filing
  6. Jul 29, 2026ResultsReleased financial results. Filing
  7. Jul 27, 2026Job cutsAnnounced job cuts or other exit costs. Filing
  8. May 18, 2026AnnouncementBoston Scientific Corporation issued a press release announcing that the Company has entered into an accelerated share repurchase agreement with JPMorgan Chase Bank, National Association for $2 billion of its common stock, as part of its previously announced $5 billion share repurchase authorization. Filing
  9. May 18, 2026AnnouncementBoston Scientific Corporation issued a press release announcing that the Company has entered into an investment agreement with MiRus LLC, a privately held company developing and commercializing proprietary novel biomaterials, implants and procedural solutions for the treatment of cardiovascular and… Filing
  10. May 5, 2026VoteReported shareholder vote results. Filing
  11. Apr 22, 2026ResultsReleased financial results. Filing
  12. Mar 30, 2026AnnouncementBoston Scientific Corporation issued a press release announcing results from the Company's HI-PEITHO clinical trial. Filing
  13. Feb 26, 2026AgreementBoston Scientific Corporation entered into a $3.000 billion revolving credit agreement by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent. Filing
  14. Feb 23, 2026LeadershipOn February 18, 2026 the Board of Directors of Boston Scientific Corporation, upon the recommendation of the Nominating and Governance Committee of the Board, increased the number of directors comprising the Board from ten to twelve, and appointed each of Catherine R. Smith and Christophe P. Weber… Filing
  15. Feb 5, 2026LeadershipYoshiaki Fujimori informed Boston Scientific Corporation that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders. Filing
  16. Feb 4, 2026ResultsReleased financial results. Filing
  17. Jan 15, 2026AgreementBoston Scientific Corporation, a Delaware corporation, entered into an Agreement and Plan of Merger with Pinehurst Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company, and Penumbra, Inc., a Delaware corporation, providing for the merger of Merger Sub with and into… Filing
  18. Jan 15, 2026AnnouncementShared information with investors. Filing
  19. Nov 19, 2025LeadershipUpon the recommendation of the Executive Compensation and Human Resources Committee, the Board of Directors of Boston Scientific Corporation approved the Company’s 2026 Annual Bonus Plan effective for the performance year of January 1, 2026 through December 31, 2026. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Boston Scientific financials

Famous investors that hold BSX

8 of the 50 well-known investors we track reported holding BSX in their latest 13F filing. The largest position is Ken Griffin's, worth $341M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 20267.81M$341M0.2%+57%
Jim Simons · Renaissance TechnologiesQ3 20261.77M$77.1M0.1%-27%
Israel Englander · Millennium ManagementQ3 20261.12M$27.1M0.0%-79%
Ray Dalio · Bridgewater AssociatesQ3 2026437,208$19.1M0.1%-1%
Ken Fisher · Fisher Asset ManagementQ3 2026292,236$12.8M0.0%-12%
Larry Robbins · Glenview Capital ManagementQ3 202670,348$3.1M0.1%-38%
Jeremy Grantham · GMOQ3 202628,600$1.2M0.0%+31%
Lee Ainslie · Maverick CapitalQ3 20265,101$223K0.0%-100%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Boston Scientific Corp (BSX) stock

Who owns the most BSX stock?

The largest reported owner of Boston Scientific Corp (BSX) is BlackRock, Inc., with 8.7% of the company. In total, 1,473 funds and institutions reported holding BSX at the end of Q2 2026, together about 97% of the shares. See the largest owners.

Are BSX insiders buying or selling?

In the last 12 months, BSX insiders reported 10 open-market purchases worth $10M and 3 sales worth $16.8M. The latest trade was on Aug 25, 2026. See every trade.

What is the short interest in BSX?

As of Oct 30, 2026, 35.11M BSX shares were sold short, 2.4% of the shares outstanding, down 13.7% from the report before. At the average daily volume of 21.26M shares, buying them all back would take about 1.6 trading days (days to cover). See the history.

Have members of Congress traded BSX?

Yes. 8 members of Congress reported 14 purchases and 22 sales of BSX since Nov 17, 2024. The latest was reported on Sep 25, 2026. See the trades.

Which famous investors hold BSX?

8 of the 50 well-known investors we track reported BSX in their latest 13F filing, including Ken Griffin, Jim Simons, Israel Englander. The largest position is worth $341M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.